ID

32861

Beschreibung

A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110); ODM derived from: https://clinicaltrials.gov/show/NCT00830076

Link

https://clinicaltrials.gov/show/NCT00830076

Stichworte

  1. 17.11.18 17.11.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

17. November 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Type 2 Diabetes Mellitus NCT00830076

Eligibility Type 2 Diabetes Mellitus NCT00830076

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
female subjects must have a negative pregnancy test
Beschreibung

Gender Pregnancy test negative

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0427780
subject has type 2 diabetes and is not currently receiving treatment with an oral aha agent, has not received such treatment for 3 months prior to study, and/or has not received more than 4 total weeks treatment with an oral aha agent for 12 to 18 months prior to the study
Beschreibung

Diabetes Mellitus, Non-Insulin-Dependent | Oral hypoglycemic Absent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0359086
UMLS CUI [2,2]
C0332197
subject is a nonsmoker or has not smoked and/or used nicotine for at least 6 months
Beschreibung

Non-smoker | Tobacco use Absent Duration

Datentyp

boolean

Alias
UMLS CUI [1]
C0337672
UMLS CUI [2,1]
C0543414
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0449238
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject has a history of stroke, seizures, or major neurological disorders
Beschreibung

Cerebrovascular accident | Seizures | Nervous system disorder Major

Datentyp

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0036572
UMLS CUI [3,1]
C0027765
UMLS CUI [3,2]
C0205164
female subject is breastfeeding
Beschreibung

Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0006147
subject cannot refrain from use of any prescription or non-prescription drugs beginning 2 weeks prior to first dose of study drug
Beschreibung

Pharmaceutical Preparations Unable to discontinue | Non-Prescription Drugs Unable to discontinue

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1548265
UMLS CUI [2,1]
C0013231
UMLS CUI [2,2]
C1548265
subject consumes more than 3 alcoholic beverages per day
Beschreibung

Consumption Alcoholic Beverages U/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001948
UMLS CUI [1,2]
C0001967
UMLS CUI [1,3]
C0456683
subject consumes more than 6 caffeinated beverages per day
Beschreibung

Consumption Caffeinated beverage U/day

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0948365
UMLS CUI [1,2]
C0678438
UMLS CUI [1,3]
C0456683
subject has had major surgery, or has donated or lost 1 unit of blood within 4 weeks of screening
Beschreibung

Major surgery | Blood Donation Unit Quantity | Blood Loss Unit Quantity

Datentyp

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2,1]
C0005794
UMLS CUI [2,2]
C0439148
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C3163616
UMLS CUI [3,2]
C0439148
UMLS CUI [3,3]
C1265611
subject has a history of cancer, except certain skin or cervical cancer or other cancers treated more than 10 years prior to screening
Beschreibung

Malignant Neoplasms | Exception Skin carcinoma | Exception Cervix carcinoma Specified | Exception Cancer Other Treated

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0302592
UMLS CUI [3,3]
C0205369
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1707251
UMLS CUI [4,3]
C1522326
subject has a history of multiple and/or severe allergies or intolerance to drugs or food
Beschreibung

DRUG ALLERGY MULTIPLE | Drug Allergy Severe | FOOD ALLERGY TO MULTIPLE FOOD | Food Allergy Severe | DRUG INTOLERANCE MULTIPLE | Drug intolerance Severe | Food intolerance multiple | Food intolerance Severe

Datentyp

boolean

Alias
UMLS CUI [1]
C0743280
UMLS CUI [2,1]
C0013182
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0744084
UMLS CUI [4,1]
C0016470
UMLS CUI [4,2]
C0205082
UMLS CUI [5]
C0743285
UMLS CUI [6,1]
C0277585
UMLS CUI [6,2]
C0205082
UMLS CUI [7,1]
C0149696
UMLS CUI [7,2]
C0439064
UMLS CUI [8,1]
C0149696
UMLS CUI [8,2]
C0205082

Ähnliche Modelle

Eligibility Type 2 Diabetes Mellitus NCT00830076

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Gender Pregnancy test negative
Item
female subjects must have a negative pregnancy test
boolean
C0079399 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent | Oral hypoglycemic Absent
Item
subject has type 2 diabetes and is not currently receiving treatment with an oral aha agent, has not received such treatment for 3 months prior to study, and/or has not received more than 4 total weeks treatment with an oral aha agent for 12 to 18 months prior to the study
boolean
C0011860 (UMLS CUI [1])
C0359086 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Non-smoker | Tobacco use Absent Duration
Item
subject is a nonsmoker or has not smoked and/or used nicotine for at least 6 months
boolean
C0337672 (UMLS CUI [1])
C0543414 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
Cerebrovascular accident | Seizures | Nervous system disorder Major
Item
subject has a history of stroke, seizures, or major neurological disorders
boolean
C0038454 (UMLS CUI [1])
C0036572 (UMLS CUI [2])
C0027765 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
Breast Feeding
Item
female subject is breastfeeding
boolean
C0006147 (UMLS CUI [1])
Pharmaceutical Preparations Unable to discontinue | Non-Prescription Drugs Unable to discontinue
Item
subject cannot refrain from use of any prescription or non-prescription drugs beginning 2 weeks prior to first dose of study drug
boolean
C0013227 (UMLS CUI [1,1])
C1548265 (UMLS CUI [1,2])
C0013231 (UMLS CUI [2,1])
C1548265 (UMLS CUI [2,2])
Consumption Alcoholic Beverages U/day
Item
subject consumes more than 3 alcoholic beverages per day
boolean
C0001948 (UMLS CUI [1,1])
C0001967 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Consumption Caffeinated beverage U/day
Item
subject consumes more than 6 caffeinated beverages per day
boolean
C0948365 (UMLS CUI [1,1])
C0678438 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Major surgery | Blood Donation Unit Quantity | Blood Loss Unit Quantity
Item
subject has had major surgery, or has donated or lost 1 unit of blood within 4 weeks of screening
boolean
C0679637 (UMLS CUI [1])
C0005794 (UMLS CUI [2,1])
C0439148 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C3163616 (UMLS CUI [3,1])
C0439148 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
Malignant Neoplasms | Exception Skin carcinoma | Exception Cervix carcinoma Specified | Exception Cancer Other Treated
Item
subject has a history of cancer, except certain skin or cervical cancer or other cancers treated more than 10 years prior to screening
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0302592 (UMLS CUI [3,2])
C0205369 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1707251 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
DRUG ALLERGY MULTIPLE | Drug Allergy Severe | FOOD ALLERGY TO MULTIPLE FOOD | Food Allergy Severe | DRUG INTOLERANCE MULTIPLE | Drug intolerance Severe | Food intolerance multiple | Food intolerance Severe
Item
subject has a history of multiple and/or severe allergies or intolerance to drugs or food
boolean
C0743280 (UMLS CUI [1])
C0013182 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0744084 (UMLS CUI [3])
C0016470 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0743285 (UMLS CUI [5])
C0277585 (UMLS CUI [6,1])
C0205082 (UMLS CUI [6,2])
C0149696 (UMLS CUI [7,1])
C0439064 (UMLS CUI [7,2])
C0149696 (UMLS CUI [8,1])
C0205082 (UMLS CUI [8,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video